125 related articles for article (PubMed ID: 18549873)
1. Cognitive neuroscience and schizophrenia: translational research in need of a translator.
Cohen JD; Insel TR
Biol Psychiatry; 2008 Jul; 64(1):2-3. PubMed ID: 18549873
[No Abstract] [Full Text] [Related]
2. New paradigms for treatment development.
Stover EL; Brady L; Marder SR
Schizophr Bull; 2007 Sep; 33(5):1093-9. PubMed ID: 17673495
[TBL] [Abstract][Full Text] [Related]
3. Measurement issues in the use of cognitive neuroscience tasks in drug development for impaired cognition in schizophrenia: a report of the second consensus building conference of the CNTRICS initiative.
Barch DM; Carter CS;
Schizophr Bull; 2008 Jul; 34(4):613-8. PubMed ID: 18499705
[TBL] [Abstract][Full Text] [Related]
4. Identifying unmet therapeutic domains in schizophrenia patients: the early contributions of Wayne Fenton from Chestnut Lodge.
McGlashan TH; Carpenter WT
Schizophr Bull; 2007 Sep; 33(5):1086-92. PubMed ID: 17634414
[TBL] [Abstract][Full Text] [Related]
5. Adapting social neuroscience measures for schizophrenia clinical trials, Part 1: ferrying paradigms across perilous waters.
Green MF; Lee J; Ochsner KN
Schizophr Bull; 2013 Nov; 39(6):1192-200. PubMed ID: 24072811
[TBL] [Abstract][Full Text] [Related]
6. Towards medication-enhancement of cognitive interventions in schizophrenia.
Chou HH; Twamley E; Swerdlow NR
Handb Exp Pharmacol; 2012; (213):81-111. PubMed ID: 23027413
[TBL] [Abstract][Full Text] [Related]
7. New translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and rats.
Bussey TJ; Holmes A; Lyon L; Mar AC; McAllister KA; Nithianantharajah J; Oomen CA; Saksida LM
Neuropharmacology; 2012 Mar; 62(3):1191-203. PubMed ID: 21530550
[TBL] [Abstract][Full Text] [Related]
8. Neurophysiological biomarkers for drug development in schizophrenia.
Javitt DC; Spencer KM; Thaker GK; Winterer G; Hajós M
Nat Rev Drug Discov; 2008 Jan; 7(1):68-83. PubMed ID: 18064038
[TBL] [Abstract][Full Text] [Related]
9. Cognition, schizophrenia, and the atypical antipsychotic drugs.
Meltzer HY; Park S; Kessler R
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13591-3. PubMed ID: 10570115
[No Abstract] [Full Text] [Related]
10. A path to novel, effective treatments for schizophrenia.
Weickert TW; Weickert CS
Neuropsychopharmacology; 2024 Jan; 49(1):321-322. PubMed ID: 37580457
[No Abstract] [Full Text] [Related]
11. Schizophrenia as a systemic disease.
Kirkpatrick B
Schizophr Bull; 2009 Mar; 35(2):381-2. PubMed ID: 19193741
[No Abstract] [Full Text] [Related]
12. FDA-Approved Drugs to Treat Schizophrenia.
J Psychosoc Nurs Ment Health Serv; 2023 Dec; 61(12):5-6. PubMed ID: 38051683
[No Abstract] [Full Text] [Related]
13. Schizophrenia.
Macher JP
Dialogues Clin Neurosci; 2010; 12(3):265. PubMed ID: 20954424
[No Abstract] [Full Text] [Related]
14. Schizophrenia.
Owen MJ; Sawa A; Mortensen PB
Lancet; 2016 Jul; 388(10039):86-97. PubMed ID: 26777917
[TBL] [Abstract][Full Text] [Related]
15. Phenotypical Screening on Neuronal Plasticity in Hippocampal-Prefrontal Cortex Connectivity Reveals an Antipsychotic with a Novel Profile.
Spedding M; Sebban C; Jay TM; Rocher C; Tesolin-Decros B; Chazot P; Schenker E; Szénási G; Lévay GI; Megyeri K; Barkóczy J; Hársing LG; Thomson I; Cunningham MO; Whittington MA; Etherington LA; Lambert JJ; Antoni FA; Gacsályi I
Cells; 2022 Mar; 11(7):. PubMed ID: 35406745
[TBL] [Abstract][Full Text] [Related]
16. Targeting sleep oscillations to improve memory in schizophrenia.
Manoach DS; Mylonas D; Baxter B
Schizophr Res; 2020 Jul; 221():63-70. PubMed ID: 32014359
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Sleep Spindles, Memory Consolidation, and Schizophrenia.
Manoach DS; Stickgold R
Annu Rev Clin Psychol; 2019 May; 15():451-479. PubMed ID: 30786245
[TBL] [Abstract][Full Text] [Related]
18. Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.
O'Tuathaigh CMP; Moran PM; Zhen XC; Waddington JL
Br J Pharmacol; 2017 Oct; 174(19):3173-3190. PubMed ID: 28667666
[TBL] [Abstract][Full Text] [Related]
19. A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia.
Kim YK; Choi J; Park SC
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28358303
[TBL] [Abstract][Full Text] [Related]
20. Neuroeconomics: a bridge for translational research.
Sharp C; Monterosso J; Montague PR
Biol Psychiatry; 2012 Jul; 72(2):87-92. PubMed ID: 22727459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
